Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2012, Article ID 796729, 14 pages
http://dx.doi.org/10.1155/2012/796729
Research Article

Adamantyl Retinoid-Related Molecules Induce Apoptosis in Pancreatic Cancer Cells by Inhibiting IGF-1R and Wnt/β-Catenin Pathways

1John D Dingell VA MC, Wayne State University, Detroit, MI 48201, USA
2Department of Oncology, Wayne State University, Detroit, MI 48201, USA
3Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA
4Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA
5Department of Neurobiology, Harvard University, Cambridge, MA 02138, USA

Received 31 October 2011; Revised 17 January 2012; Accepted 30 January 2012

Academic Editor: Reidar Grenman

Copyright © 2012 Lulu Farhana et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Bednar and D. M. Simeone, “Pancreatic cancer stem cells and relevance to cancer treatments,” Journal of Cellular Biochemistry, vol. 107, no. 1, pp. 40–45, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. M. F. Clarke, J. E. Dick, P. B. Dirks et al., “Cancer stem cells—perspectives on current status and future directions: AACR workshop on cancer stem cells,” Cancer Research, vol. 66, no. 19, pp. 9339–9344, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. P. C. Hermann, S. L. Huber, T. Herrler et al., “Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer,” Cell Stem Cell, vol. 1, no. 3, pp. 313–323, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. C. J. Lee, J. Dosch, and D. M. Simeone, “Pancreatic cancer stem cells,” Journal of Clinical Oncology, vol. 26, no. 17, pp. 2806–2812, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Farhana, M. I. Dawson, Z. Xia et al., “Adamantyl-substituted retinoid-related molecules induce apoptosis in human acute myelogenous leukemia cells,” Molecular Cancer Therapeutics, vol. 9, no. 11, pp. 2903–2913, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Zhang, M. I. Dawson, R. Mohammad et al., “Induction of apoptosis of human B-CLL and ALL cells by a novel retinoid and its nonretinoidal analog,” Blood, vol. 100, no. 8, pp. 2917–2925, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Farhana, M. I. Dawson, F. Murshed, and J. A. Fontana, “Maximal adamantyl-substituted retinoid-related molecule-induced apoptosis requires NF-B noncanonical and canonical pathway activation,” Cell Death and Differentiation, vol. 18, no. 1, pp. 164–173, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Zhang, J. Soto, K. Park et al., “Nuclear receptor SHP, a death receptor that targets mitochondria, induces apoptosis and inhibits tumor growth,” Molecular and Cellular Biology, vol. 30, no. 6, pp. 1341–1356, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. H. Han, X. Cao, B. Lin et al., “Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt,” Oncogene, vol. 25, no. 21, pp. 2974–2986, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. D. L. Spector, R. D. Goldman, and L. A. Leinwand, Cells- A Laboratory Manual: Culture and Biochemical Analysis of Cells, vol. 1, Goldspring Harbor Laboratory Press, Cold Spring Harbor, NY, USA, 1998.
  11. L. Farhana, M. I. Dawson, M. Leid et al., “Adamantyl-substituted retinoid-related molecules bind small heterodimer partner and modulate the Sin3A repressor,” Cancer Research, vol. 67, no. 1, pp. 318–325, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. A. N. Shah, J. M. Summy, J. Zhang, S. I. Park, N. U. Parikh, and G. E. Gallick, “Development and characterization of gemcitabine-resistant pancreatic tumor cells,” Annals of Surgical Oncology, vol. 14, no. 12, pp. 3629–3637, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Zhou, C. Y. Wang, T. Liu et al., “Persistence of side population cells with high drug efflux capacity in pancreatic cancer,” World Journal of Gastroenterology, vol. 14, no. 6, pp. 925–930, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Jimeno, G. Feldmann, A. Suárez-Gauthier et al., “A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development,” Molecular Cancer Therapeutics, vol. 8, no. 2, pp. 310–314, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. P. H. Sung, J. Wen, S. Bang, S. Park, and Y. S. Si, “CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells,” International Journal of Cancer, vol. 125, no. 10, pp. 2323–2331, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Li, D. G. Heidt, P. Dalerba et al., “Identification of pancreatic cancer stem cells,” Cancer Research, vol. 67, no. 3, pp. 1030–1037, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. J. L. Dembinski and S. Krauss, “Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma,” Clinical and Experimental Metastasis, vol. 26, no. 7, pp. 611–623, 2009. View at Publisher · View at Google Scholar
  18. M. T. Mueller, P. C. Hermann, J. Witthauer et al., “Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer,” Gastroenterology, vol. 137, no. 3, pp. 1102–1113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Quante and T. C. Wang, “Stem cells in gastroenterology and hepatology,” Nature Reviews Gastroenterology and Hepatology, vol. 6, no. 12, pp. 724–737, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. O. Gires, C. A. Klein, and P. A. Baeuerle, “On the abundance of EpCAM on cancer stem cells,” Nature Reviews Cancer, vol. 9, no. 2, p. 143, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. M. T. Yip-Schneider, H. Wu, M. Ralstin et al., “Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo,” Molecular Cancer Therapeutics, vol. 6, no. 6, pp. 1736–1744, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. J. Li, Z. M. Wei, Y. X. Y. X. Meng, and X. R. Ji, “β-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis,” World Journal of Gastroenterology, vol. 11, no. 14, pp. 2117–2123, 2005. View at Google Scholar · View at Scopus
  23. Z. Wang and Q. Ma, “β-Catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer,” Medical Hypotheses, vol. 69, no. 4, pp. 816–820, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Ma, H. Sawai, Y. Matsuo et al., “IGF-1 Mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/AKT signaling pathway in pancreatic cancer cells,” Journal of Surgical Research, vol. 160, no. 1, pp. 90–101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. O. Stoeltzing, W. Liu, N. Reinmuth et al., “Regulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer,” American Journal of Pathology, vol. 163, no. 3, pp. 1001–1011, 2003. View at Google Scholar · View at Scopus
  26. T. W. Bauer, R. J. Somcio, F. Fan et al., “Regulatory role of c-Met in insulin-like growth factor-I receptor—mediated migration and invasion of human pancreatic carcinoma cells,” Molecular Cancer Therapeutics, vol. 5, no. 7, pp. 1676–1682, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Katoh and M. Katoh, “WNT signaling pathway and stem cell signaling network,” Clinical Cancer Research, vol. 13, no. 14, pp. 4042–4045, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Li, M. S. Wicha, S. J. Schwartz, and D. Sun, “Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds,” Journal of Nutritional Biochemistry, vol. 22, no. 9, pp. 799–806, 2011. View at Publisher · View at Google Scholar
  29. C. Y. Logan and R. Nusse, “The Wnt signaling pathway in development and disease,” Annual Review of Cell and Developmental Biology, vol. 20, pp. 781–810, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Farhana, M. I. Dawson, L. Xu, and J. A. Fontana, “SHP and Sin3A expression are essential for adamantyl-substituted retinoid-related molecule-mediated nuclear factor-κB activation, c-Fos/c-Jun expression, and cellular apoptosis,” Molecular Cancer Therapeutics, vol. 8, no. 6, pp. 1625–1635, 2009. View at Publisher · View at Google Scholar
  31. S. Y. Sun, P. Yue, L. Mao et al., “Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells,” Clinical Cancer Research, vol. 6, no. 4, pp. 1563–1573, 2000. View at Google Scholar · View at Scopus
  32. L. Mologni, I. Ponzanelli, F. Bresciani et al., “The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2- naphthalene carboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases,” Blood, vol. 93, no. 3, pp. 1045–1061, 1999. View at Google Scholar · View at Scopus
  33. S. Y. Sun, P. Yue, R. A. S. Chandraratna, Y. Tesfaigzi, W. K. Hong, and R. Lotan, “Dual mechanisms of action of the retinoid CD437: nuclear retinoic acid receptor-mediated suppression of squamous differentiation and receptor-independent induction of apoptosis in UMSCC22B human head and neck squamous cell carcinoma cells,” Molecular Pharmacology, vol. 58, no. 3, pp. 508–514, 2000. View at Google Scholar · View at Scopus
  34. X. P. Lu, A. Fanjul, N. Picard et al., “Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo,” Nature Medicine, vol. 3, no. 6, pp. 686–690, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Miao, S.-E. Choi, S. M. Seok et al., “Ligand-dependent regulation of the activity of the orphan nuclear receptor, small heterodimer partner (SHP), in the repression of bile acid biosynthetic CYP7A1 and CYP8B1 genes,” Molecular Endocrinology, vol. 25, no. 7, pp. 1159–1169, 2011. View at Publisher · View at Google Scholar
  36. P. C. Hermann, S. Bhaskar, M. Cioffi, and C. Heeschen, “Cancer stem cells in solid tumors,” Seminars in Cancer Biology, vol. 20, no. 2, pp. 77–84, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Huang, C. Y. Wang, S. M. Gou, H. S. Wu, T. Liu, and J. X. Xiong, “Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma,” World Journal of Gastroenterology, vol. 14, no. 24, pp. 3903–3907, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. D. M. Simeone, “Pancreatic cancer stem cells: implications for the treatment of pancreatic cancer,” Clinical Cancer Research, vol. 14, no. 18, pp. 5646–5648, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. M. P. Kim, J. B. Fleming, H. Wang et al., “ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma,” PLoS ONE, vol. 6, no. 6, 2011. View at Publisher · View at Google Scholar
  40. N. A. Dallas, L. Xia, F. Fan et al., “Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition,” Cancer Research, vol. 69, no. 5, pp. 1951–1957, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. L. C. Murtaugh, A. C. Law, Y. Dor, and D. A. Melton, “β-Catenin is essential for pancreatic acinar but not islet development,” Development, vol. 132, no. 21, pp. 4663–4674, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Papadopoulou and H. Edlund, “Attenuated Wnt signaling perturbs pancreatic growth but not pancreatic function,” Diabetes, vol. 54, no. 10, pp. 2844–2851, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. A. M. Lowy, C. Fenoglio-Preiser, O. J. Kim et al., “Dysregulation of β-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinoma,” Annals of Surgical Oncology, vol. 10, no. 3, pp. 284–290, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Zeng, M. Germinaro, A. Micsenyi et al., “Aberrant Wnt/β-catenin signaling in pancreatic adenocarcinoma,” Neoplasia, vol. 8, no. 4, pp. 279–289, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. P. W. Heiser, D. A. Cano, L. Landsman et al., “Stabilization of β-catenin induces pancreas tumor formation,” Gastroenterology, vol. 135, no. 4, pp. 1288–1300, 2008. View at Publisher · View at Google Scholar · View at Scopus